Inhibiting the phosphorylation of MAPK1 can reduce cardiomyocyte apoptosis and slow down the progression of myocardial hypertrophy (Huang et al., 2018; Ruan et al., 2021). This evidence concerns the gene MAPK1 and cardiac hypertrophy.